Assistant Professor, Global Health
Dr. Arianna Rubin-Means, MPH, PhD focuses on generating operational evidence needed to improve the delivery of routine primary healthcare programs in low and middle-income countries, both within health facilities and in communities. She is currently the implementation science lead for the DeWorm3 Project, a series of large hybrid cluster randomized trials in Benin, India, and Malawi. She designs and manages the DeWorm3 Project’s qualitative research studies, organizational readiness research, operational research process mapping studies, and economic evaluations. She also leads implementation science activities for a multi-country network of facility-based child mortality studies, which aim to improve care for acutely ill children living in countries with limited resources and prevent both in-hospital and post-discharge mortality. Dr. Means teaches the online Fundamentals of Implementation Science course, providing training to over 200 implementation scientists around the world, as well as the annual CFAR implementation science mini-course.
A trained epidemiologist and implementation scientist, Dr. Means’ area of expertise is integrating evaluation of implementation outcomes into clinically oriented research to ensure that findings translate into the evidence needed to inform policy and guidelines. Dr. Means is a Scientific Associate at the Natural History Museum in London and an Associate Editor for PLOS Neglected Tropical Diseases.
Publications
- Healy, E, Means, AR, Knudtson, K, Frank, N, Juarez, A, Prohaska, S et al.. Facilitators and barriers to monitoring and evaluation at syringe service programs. Harm Reduct J. 2024;21 (1):157. doi: 10.1186/s12954-024-01073-z. PubMed PMID:39192340 .
- Tiwari, R, Tickell, KD, Yoshioka, E, Otieno, J, Shah, A, Richardson, BA et al.. Lactoferrin and lysozyme to promote nutritional, clinical and enteric recovery: a protocol for a factorial, blinded, placebo-controlled randomised trial among children with diarrhoea and malnutrition (the Boresha Afya trial). BMJ Open. 2024;14 (8):e079448. doi: 10.1136/bmjopen-2023-079448. PubMed PMID:39122384 PubMed Central PMC11331881.
- Morozoff, C, Ahmed, N, Chinkhumba, J, Islam, MT, Jallow, AF, Ogwel, B et al.. Quantifying the Cost of Shigella Diarrhea in the Enterics for Global Health (EFGH) Shigella Surveillance Study. Open Forum Infect Dis. 2024;11 (Suppl 1):S41-S47. doi: 10.1093/ofid/ofad575. PubMed PMID:38532961 PubMed Central PMC10962725.
- Aruldas, K, Johnson, J, Saxena, M, Titus, A, Roll, A, Ramesh, RM et al.. Adolescents' Perspective Regarding a Community-Wide Mass Drug Administration Program for Soil-Transmitted Helminths in India. Am J Trop Med Hyg. 2024;110 (4):681-686. doi: 10.4269/ajtmh.23-0676. PubMed PMID:38471161 PubMed Central PMC10993849.
- Shawon, RA, Denno, D, Tickell, KD, Atuhairwe, M, Bandsma, R, Mupere, E et al.. Prevalence and correlates of paediatric guideline non-adherence for initial empirical care in six low and middle-income settings: a hospital-based cross-sectional study. BMJ Open. 2024;14 (3):e078404. doi: 10.1136/bmjopen-2023-078404. PubMed PMID:38458789 PubMed Central PMC10928745.